Clinical Trials Directory

Trials / Sponsors / TauRx Therapeutics Ltd

TauRx Therapeutics Ltd

Industry · 11 registered clinical trials.

StatusTrialPhaseStarted
CompletedSafety and Efficacy of TRx0237 in Subjects With Alzheimer's Disease Followed by Open-Label Treatment
Alzheimer Disease
Phase 32017-12-01
TerminatedOpen-Label Study of Leuco-methylthioninium Bis(Hydromethanesulfonate) (LMTM) in Subjects With Alzheimer's Dise
Alzheimer's Disease, Behavioral Variant Frontotemporal Dementia
Phase 32014-08-01
CompletedSafety and Efficacy Study Evaluating TRx0237 in Subjects With Behavioral Variant Frontotemporal Dementia (bvFT
Behavioral Variant Frontotemporal Dementia (bvFTD)
Phase 32013-05-01
CompletedSafety and Efficacy Study Evaluating TRx0237 in Subjects With Mild to Moderate Alzheimer's Disease
Alzheimer's Disease
Phase 32013-01-01
CompletedSafety and Efficacy Study Evaluating TRx0237 in Subjects With Mild Alzheimer's Disease
Alzheimer's Disease
Phase 32012-10-01
TerminatedSafety Study of TRx0237 in Patients Already Taking Medications for Mild and Moderate Alzheimer's Disease
Alzheimer's Disease
Phase 22012-09-01
CompletedMultiple Dose Study of TRx0037
Alzheimer's Disease
Phase 12010-03-01
CompletedComparative Bioavailability in Healthy Elderly Volunteers
Alzheimer's Disease
Phase 12010-02-01
CompletedOpen Label Study of TRx0014 in Alzheimer's Disease
Alzheimer's Disease
Phase 22007-09-13
CompletedTRx0014 in Patients With Mild or Moderate Alzheimer's Disease
Dementia, Alzheimer Type
Phase 22004-08-01
AvailableTRx0237 for the Treatment of Early and Mild-Moderate Alzheimer's Disease
Alzheimer Disease
——